Drug Shortage Report for TARO-TESTOSTERONE

Last updated on 2020-01-13 History
Report ID 102347
Drug Identification Number 02421186
Brand name TARO-TESTOSTERONE
Common or Proper name TESTOSTERONE
Company Name TARO PHARMACEUTICALS INC
Active Ingredient(s) TESTOSTERONE UNDECANOATE
Strength(s) 40MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 60 blister
ATC code G03BA
ATC description ANDROGENS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-01-02
Estimated end date 2020-01-17
Actual end date 2020-01-10
Shortage status Resolved
Updated date 2020-01-13
Company comments
Health Canada comments
Contact Address 130 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-01-13 French Compare
v3 2020-01-13 English Compare
v2 2020-01-04 French Compare
v1 2020-01-04 English Compare